Home / Irbesartan / Czechia
CZ ATC C09CA04 · updated 2 Nov 2026
Irbesartan shortage in Czechia
Is there an Irbesartan shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Irbesartan product is reported short in Czechia, the first since 4 Sep 2026. The company estimate for the return is 6 Nov 2026. Main reason: commercial decision or withdrawal.
Also short in Canada, Italy, Sweden, Japan, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | ISAME 150MG 150MG TBL NOB 100 | Medochemie Ltd., Limassol | 4 Sep 2026 | 6 Nov 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.